Market News AIOpen the app

Co-Diagnostics, Inc.: Entry into a Material Definitive Agreement (CODX)

New sharesRead the original at SEC EDGAR
Bad for CODX

Co-Diagnostics received $960,000 in working cash, but must make weekly payments on a $1.35 million secured note. The repayment burden, lien on nearly all assets, and possible share conversion make this unfavorable.

CODX · Co-Diagnostics, Inc.

AI read · Bad for CODX

The AI's read

The cash gives Co-Diagnostics funds for working capital, but it comes with frequent payments and a senior claim on nearly all company assets. The lender can also turn amounts due into shares. Missing the required reverse-split deadline can trigger default. These burdens outweigh the cash benefit.

Get alerts for CODX

Follow Co-Diagnostics, Inc. (CODX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CODX
Free on the App Store and Google Play, or on the web.